Cargando…

Predicting Paclitaxel Disposition in Humans With Whole‐Body Physiologically‐Based Pharmacokinetic Modeling

Paclitaxel is a commonly used drug in the treatment of multiple solid tumors, including cancers of the breast, lung, and ovaries. Despite the established exposure–pharmacodynamic relationships for paclitaxel, treatment is associated with wide interindividual pharmacokinetic variability that leads to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Qiang, Sun, Xinxin, Lustburg, Maryam B., Sparreboom, Alex, Hu, Shuiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930855/ https://www.ncbi.nlm.nih.gov/pubmed/31671477 http://dx.doi.org/10.1002/psp4.12472

Ejemplares similares

Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice
por: Anderson, Jason T., et al.
Publicado: (2019)

Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
por: Fu, Qiang, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Model To Predict Metoprolol Disposition in Healthy and Disease Populations
por: Zamir, Ammara, et al.
Publicado: (2023)

Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans
por: Jagdale, Prabhas, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel
por: Chen, Nianhang, et al.
Publicado: (2014)

Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy
por: Amaeze, Ogochukwu U., et al.
Publicado: (2023)

Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human
por: Chen, Yang, et al.
Publicado: (2016)

Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
por: Alqahtani, Saeed, et al.
Publicado: (2015)

Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children
por: Verscheijden, Laurens F. M., et al.
Publicado: (2021)

Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy
por: Guo, Sijin, et al.
Publicado: (2020)

Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
por: Khalid, Sundus, et al.
Publicado: (2023)

A physiologically‐based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites
por: Ramachandran, Aparna, et al.
Publicado: (2023)

Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy
por: Stage, Tore B., et al.
Publicado: (2020)

Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
por: Li, Yang, et al.
Publicado: (2021)

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
por: Chang, Hsuan Ping, et al.
Publicado: (2021)

Pharmacokinetics and Disposition of Heparin-Binding Growth Factor Midkine Antisense Oligonucleotide Nanoliposomes in Experimental Animal Species and Prediction of Human Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model
por: Bai, Haihong, et al.
Publicado: (2021)

Cocaine: analysis, pharmacokinetics, and metabolic disposition.
por: Jatlow, P.
Publicado: (1988)

Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
por: Gardner, Erin R, et al.
Publicado: (2009)

Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats
por: Scotcher, Daniel, et al.
Publicado: (2021)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
por: Murata, Yukiko, et al.
Publicado: (2022)

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
por: Schlender, Jan-Frederik, et al.
Publicado: (2016)

Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
por: Scripture, Charity D, et al.
Publicado: (2005)

Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section
por: Alrammaal, Hanadi H., et al.
Publicado: (2022)

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)

A “middle‐out approach” for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models
por: Yau, Estelle, et al.
Publicado: (2023)

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans
por: Li, Ying Fei, et al.
Publicado: (2018)

Physiologically based pharmacokinetic modeling for predicting irinotecan exposure in human body
por: Fan, Yingfang, et al.
Publicado: (2017)

Database of Optimized Proteomic Quantitative Methods for Human Drug Disposition‐Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling
por: Vrana, M, et al.
Publicado: (2017)

A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
por: Emoto, Chie, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Models for Adults and Children Reveal a Role of Intracellular Tubulin Binding in Vincristine Disposition
por: Lee, Christine M., et al.
Publicado: (2019)

A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
por: Niederalt, Christoph, et al.
Publicado: (2017)

Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
por: Puttrevu, Santosh Kumar, et al.
Publicado: (2020)

Pharmacokinetic Models for FcRn-Mediated IgG Disposition
por: Xiao, Jim J.
Publicado: (2012)

Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy
por: Velasquez, Juan C., et al.
Publicado: (2016)

Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
por: Avedissian, Sean N., et al.
Publicado: (2021)

Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
por: Tsunoda, Shirley M., et al.
Publicado: (2021)

Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
por: Jeong, Yoo-Seong, et al.
Publicado: (2021)

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
por: Gao, Bo, et al.
Publicado: (2018)

Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans
por: Valic, Michael S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tv01og5crc9aeqcnaoc1j9bmd3